The metabolic abnormalities caused by DM can lead to a series of cardiovascular complications, and Chi3l1 can be an effective diagnostic marker and potential therapeutic target for vascular complications in patients with both T1DM and T2DM [227,228]. This evidence concerns the gene CHI3L1 and dermatomyositis.